These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26901429)

  • 1. One-pot synthesis of pH-responsive hybrid nanogel particles for the intracellular delivery of small interfering RNA.
    Khaled SZ; Cevenini A; Yazdi IK; Parodi A; Evangelopoulos M; Corbo C; Scaria S; Hu Y; Haddix SG; Corradetti B; Salvatore F; Tasciotti E
    Biomaterials; 2016 May; 87():57-68. PubMed ID: 26901429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-targeting and pH/redox-responsive multi-layered nanocomplexes for smart co-delivery of doxorubicin and siRNA.
    Han L; Tang C; Yin C
    Biomaterials; 2015 Aug; 60():42-52. PubMed ID: 25982552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction/photo dual-responsive polymeric prodrug nanoparticles for programmed siRNA and doxorubicin delivery.
    Wu M; Li J; Lin X; Wei Z; Zhang D; Zhao B; Liu X; Liu J
    Biomater Sci; 2018 May; 6(6):1457-1468. PubMed ID: 29770812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor acidity-sensitive linkage-bridged block copolymer for therapeutic siRNA delivery.
    Xu CF; Zhang HB; Sun CY; Liu Y; Shen S; Yang XZ; Zhu YH; Wang J
    Biomaterials; 2016 May; 88():48-59. PubMed ID: 26945455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells.
    Song Y; Tang C; Yin C
    Biomaterials; 2018 Dec; 185():117-132. PubMed ID: 30241030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
    Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
    Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.
    Li Z; Zhang L; Tang C; Yin C
    Pharm Res; 2017 Dec; 34(12):2829-2841. PubMed ID: 28948461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.
    Zhuang J; Chen S; Hu Y; Yang F; Huo Q; Xie N
    Int J Nanomedicine; 2021; 16():1961-1976. PubMed ID: 33727809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-pH-Responsive and Tumor-Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti-Cancer Efficacy.
    Xu X; Wu J; Liu Y; Yu M; Zhao L; Zhu X; Bhasin S; Li Q; Ha E; Shi J; Farokhzad OC
    Angew Chem Int Ed Engl; 2016 Jun; 55(25):7091-7094. PubMed ID: 27140428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of pH-Responsive Organic-Inorganic Hybrid Nanoparticles for RNAi-Based Therapeutics.
    Wang L; Yan Y
    Macromol Biosci; 2021 Sep; 21(9):e2100183. PubMed ID: 34160896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision combination therapy for triple negative breast cancer via biomimetic polydopamine polymer core-shell nanostructures.
    Ding Y; Su S; Zhang R; Shao L; Zhang Y; Wang B; Li Y; Chen L; Yu Q; Wu Y; Nie G
    Biomaterials; 2017 Jan; 113():243-252. PubMed ID: 27829203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo.
    Lin D; Cheng Q; Jiang Q; Huang Y; Yang Z; Han S; Zhao Y; Guo S; Liang Z; Dong A
    Nanoscale; 2013 May; 5(10):4291-301. PubMed ID: 23552843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
    Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
    ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of siRNA pre-Exposure on Subsequent Response to siRNA Therapy.
    Aliabadi HM; Mahdipoor P; Kucharsky C; Chan N; Uludağ H
    Pharm Res; 2015 Dec; 32(12):3813-26. PubMed ID: 26129766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice.
    Jadidi-Niaragh F; Atyabi F; Rastegari A; Kheshtchin N; Arab S; Hassannia H; Ajami M; Mirsanei Z; Habibi S; Masoumi F; Noorbakhsh F; Shokri F; Hadjati J
    J Control Release; 2017 Jan; 246():46-59. PubMed ID: 27993599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer.
    Chen G; Wang Y; Wu P; Zhou Y; Yu F; Zhu C; Li Z; Hang Y; Wang K; Li J; Sun M; Oupicky D
    ACS Nano; 2018 Jul; 12(7):6620-6636. PubMed ID: 29985577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy.
    Wang Y; Xie Y; Kilchrist KV; Li J; Duvall CL; Oupický D
    ACS Appl Mater Interfaces; 2020 Jan; 12(4):4308-4322. PubMed ID: 31939276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan nanoparticle-delivered siRNA reduces
    Yu S; Chen Y; Li X; Gao Z; Liu G
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28446538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells.
    Yi Y; Kim HJ; Zheng M; Mi P; Naito M; Kim BS; Min HS; Hayashi K; Perche F; Toh K; Liu X; Mochida Y; Kinoh H; Cabral H; Miyata K; Kataoka K
    J Control Release; 2019 Feb; 295():268-277. PubMed ID: 30639386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery.
    Ngamcherdtrakul W; Sangvanich T; Reda M; Gu S; Bejan D; Yantasee W
    Int J Nanomedicine; 2018; 13():4015-4027. PubMed ID: 30022824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.